Journal articles on the topic 'Novel psychoactive substances (NPSs)'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Novel psychoactive substances (NPSs).'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Chung, Heesun, Jaesin Lee, and Eunmi Kim. "Trends of novel psychoactive substances (NPSs) and their fatal cases." Forensic Toxicology 34, no. 1 (2015): 1–11. http://dx.doi.org/10.1007/s11419-015-0286-5.
Full textKelečević, Igor, Ljubica Gugleta, Ana-Marija Vejnović, and Vesna Mijatović Jovin. "New Synthetic Compounds with Psychoactive Action—Preliminary Results Among Primary and High School Students on the Territory of Novi Sad." Medicines 12, no. 1 (2025): 6. https://doi.org/10.3390/medicines12010006.
Full textAlmeida, Ana Sofia, Paula Guedes de Pinho, Fernando Remião, and Carla Fernandes. "Uncovering the Metabolic Footprint of New Psychoactive Substances by Metabolomics: A Systematic Review." Molecules 30, no. 2 (2025): 290. https://doi.org/10.3390/molecules30020290.
Full textTan, Fang, Jamie P. Smith, Oliver B. Sutcliffe, and Craig E. Banks. "Regal electrochemistry: sensing of the synthetic cathinone class of new psychoactive substances (NPSs)." Analytical Methods 7, no. 16 (2015): 6470–74. http://dx.doi.org/10.1039/c5ay01820j.
Full textHiggins, Kathryn, Nina O’Neill, Leeanne O’Hara, et al. "Evidence for public health on novel psychoactive substance use: a mixed-methods study." Public Health Research 7, no. 14 (2019): 1–150. http://dx.doi.org/10.3310/phr07140.
Full textdos Santos, Christiano, and Aline Thais Bruni. "Evaluation of Density Functional Theory-Generated Data for Infrared Spectroscopy of Novel Psychoactive Substances Using Unsupervised Learning." Psychoactives 3, no. 2 (2024): 265–84. http://dx.doi.org/10.3390/psychoactives3020017.
Full textGreco, Enrico. "AI Methods for New Psychoactive Substance (NPS) Design and Analysis." Analytica 6, no. 2 (2025): 17. https://doi.org/10.3390/analytica6020017.
Full textLovrecic, Barbara, Mercedes Lovrecic, Branko Gabrovec, et al. "Non-Medical Use of Novel Synthetic Opioids: A New Challenge to Public Health." International Journal of Environmental Research and Public Health 16, no. 2 (2019): 177. http://dx.doi.org/10.3390/ijerph16020177.
Full textParrott, A. C., O. Corazza, F. Schifano, et al. "Editorial: Second International Conference on Novel Psychoactive Substances (NPSs): Keynote Addresses and Conference Abstracts." Current Drug Abuse Reviews 6, no. 4 (2014): 255–56. http://dx.doi.org/10.2174/187447370604140616121012.
Full textMartinotti, G., C. Montemitro, M. Corbo, et al. "Use of Novel Psychoactive Substances and Induced Psychiatric Symptoms: Outcomes From the Eivissa Project." European Psychiatry 41, S1 (2017): S206. http://dx.doi.org/10.1016/j.eurpsy.2017.01.2164.
Full textRicci, Valerio, Giuseppe Maina, and Giovanni Martinotti. "Rethinking Mental Automatism: De Clérambault’s Theory in the Age of Novel Psychoactive Drugs: Psychotropic Effects and Synthetic Psychosis." Healthcare 12, no. 12 (2024): 1172. http://dx.doi.org/10.3390/healthcare12121172.
Full textMiller, Bryan Lee, John M. Stogner, J. Mitchell Miller, and M. Isabel Fernandez. "The Arrest and Synthetic Novel Psychoactive Drug Relationship." Journal of Drug Issues 47, no. 1 (2016): 91–103. http://dx.doi.org/10.1177/0022042616678611.
Full textPisanu, Augusta, Giacomo Lo Russo, Giuseppe Talani, et al. "Effects of the Phenethylamine 2-Cl-4,5-MDMA and the Synthetic Cathinone 3,4-MDPHP in Adolescent Rats: Focus on Sex Differences." Biomedicines 10, no. 10 (2022): 2336. http://dx.doi.org/10.3390/biomedicines10102336.
Full textBersani, Francesco Saverio, Ornella Corazza, Gabriella Albano, et al. "25C-NBOMe: Preliminary Data on Pharmacology, Psychoactive Effects, and Toxicity of a New Potent and Dangerous Hallucinogenic Drug." BioMed Research International 2014 (2014): 1–6. http://dx.doi.org/10.1155/2014/734749.
Full textGameli, Prince Sellase, Johannes Kutzler, Diletta Berardinelli, Jeremy Carlier, Volker Auwärter, and Francesco Paolo Busardò. "Exploring the Metabolism of Flubrotizolam, a Potent Thieno-Triazolo Diazepine, Using Human Hepatocytes and High-Resolution Mass Spectrometry." Metabolites 14, no. 9 (2024): 506. http://dx.doi.org/10.3390/metabo14090506.
Full textFlorou, Dimitra, Thalia Vlachou, Vasilios Sakkas, and Vassiliki Boumba. "Application of Fabric Phase Sorptive Extraction (FPSE) Engaged to Tandem LC-MS/MS for Quantification of Brorphine in Oral Fluid." Journal of Xenobiotics 12, no. 4 (2022): 356–64. http://dx.doi.org/10.3390/jox12040025.
Full textRicci, Valerio, Giovanni Martinotti, and Giuseppe Maina. "Substance-Induced Psychosis: Diagnostic Challenges and Phenomenological Insights." Psychiatry International 5, no. 4 (2024): 759–72. http://dx.doi.org/10.3390/psychiatryint5040052.
Full textProtti, Michele, Ina Varfaj, Andrea Carotti, et al. "Microsampling and enantioselective liquid chromatography coupled to mass spectrometry for chiral bioanalysis of novel psychoactive substances." Talanta 257 (February 9, 2023): 124332. https://doi.org/10.1016/j.talanta.2023.124332.
Full textJurowski, Kamil, and Łukasz Niżnik. "Toxicity of the New Psychoactive Substance (NPS) Clephedrone (4-Chloromethcathinone, 4-CMC): Prediction of Toxicity Using In Silico Methods for Clinical and Forensic Purposes." International Journal of Molecular Sciences 25, no. 11 (2024): 5867. http://dx.doi.org/10.3390/ijms25115867.
Full textAlshamaileh, Majed, Issam Hussain, Mark Baron, Ruth Croxton, Marleen Vetter, and Jose Gonzalez-Rodriguez. "A study of in vitro metabolism and cytotoxicity of mephedrone and methoxetamine in human and pig liver models using GC/MS and LC/MS analyses." Open Chemistry 18, no. 1 (2020): 1507–22. http://dx.doi.org/10.1515/chem-2020-0184.
Full textAlshamaileh, Majed, Issam Hussain, Mark Baron, Ruth Croxton, Marleen Vetter, and Jose Gonzalez-Rodriguez. "A study of in vitro metabolism and cytotoxicity of mephedrone and methoxetamine in human and pig liver models using GC/MS and LC/MS analyses." Open Chemistry 18, no. 1 (2020): 1507–22. http://dx.doi.org/10.1515/chem-2020-0184.
Full textScotton, William J., Lisa J. Hill, Adrian C. Williams, and Nicholas M. Barnes. "Serotonin Syndrome: Pathophysiology, Clinical Features, Management, and Potential Future Directions." International Journal of Tryptophan Research 12 (January 2019): 117864691987392. http://dx.doi.org/10.1177/1178646919873925.
Full textLenzi, Monia, Sofia Gasperini, Veronica Cocchi, Micaela Tirri, Matteo Marti, and Patrizia Hrelia. "Genotoxicological Characterization of (±)cis-4,4′-DMAR and (±)trans-4,4′-DMAR and Their Association." International Journal of Molecular Sciences 23, no. 10 (2022): 5849. http://dx.doi.org/10.3390/ijms23105849.
Full textSantos, Inês C., Daniela Maia, Ricardo Jorge Dinis-Oliveira, and Daniel José Barbosa. "New Psychoactive Substances: Health and Legal Challenges." Psychoactives 3, no. 2 (2024): 285–302. http://dx.doi.org/10.3390/psychoactives3020018.
Full textBusardò, Francesco, and Simona Pichini. "Molecular Insights on New Psychoactive Substances (NPSs)." International Journal of Molecular Sciences 23, no. 6 (2022): 3282. http://dx.doi.org/10.3390/ijms23063282.
Full textSmith, Jamie P., Oliver B. Sutcliffe, and Craig E. Banks. "An overview of recent developments in the analytical detection of new psychoactive substances (NPSs)." Analyst 140, no. 15 (2015): 4932–48. http://dx.doi.org/10.1039/c5an00797f.
Full textGonçalves, Joana, Ângelo Luís, Eugenia Gallardo, and Ana Paula Duarte. "Psychoactive Substances of Natural Origin: Toxicological Aspects, Therapeutic Properties and Analysis in Biological Samples." Molecules 26, no. 5 (2021): 1397. http://dx.doi.org/10.3390/molecules26051397.
Full textMijatović Jovin, Vesna, Nina Skoko, Ana Tomas, et al. "New Psychoactive Substances: Awareness and Attitudes of Future Health Care Professionals in Serbia." International Journal of Environmental Research and Public Health 19, no. 22 (2022): 14877. http://dx.doi.org/10.3390/ijerph192214877.
Full textPiechaczek, Małgorzata, Magdalena Smolik, Sebastian Rojek, and Beata Bystrowska. "Metabolism testing methods as exemplified by selected new psychoactive substances (NPSs)." Problems of Forensic Sciences, no. 126-127 (March 29, 2022): 121–35. http://dx.doi.org/10.4467/12307483pfs.20.007.15447.
Full textGolub, Aniela, Michal Ordak, Tadeusz Nasierowski, and Magdalena Bujalska-Zadrozny. "Advanced Biomarkers of Hepatotoxicity in Psychiatry: A Narrative Review and Recommendations for New Psychoactive Substances." International Journal of Molecular Sciences 24, no. 11 (2023): 9413. http://dx.doi.org/10.3390/ijms24119413.
Full textTurcu, Teodora-Adela, Andreea Lescaie, Andreea Rodica Grama, et al. "Patterns and Emerging Trends in Acute Poisoning with Substances of Abuse Used for Recreational Purposes in Adolescents: A Six-Year Multicentre Study." Life 14, no. 8 (2024): 1033. http://dx.doi.org/10.3390/life14081033.
Full textBrew, Iain. "Novel psychoactive substances." British Journal of General Practice 66, no. 644 (2016): 125.2–125. http://dx.doi.org/10.3399/bjgp16x684253.
Full textWood, David M., and Paul I. Dargan. "Novel Psychoactive Substances." Therapeutic Drug Monitoring 34, no. 4 (2012): 363–67. http://dx.doi.org/10.1097/ftd.0b013e31825b954b.
Full textOrsolini, L., D. Papanti, R. Vecchiotti, A. Valchera, J. Corkery, and F. Schifano. "Novel psychoactive substances." European Psychiatry 33, S1 (2016): S59—S60. http://dx.doi.org/10.1016/j.eurpsy.2016.01.945.
Full textAwuchi, Chinaza Godswill, Maduabuchi Patrick Aja, Nancy Bonareri Mitaki, et al. "New Psychoactive Substances: Major Groups, Laboratory Testing Challenges, Public Health Concerns, and Community-Based Solutions." Journal of Chemistry 2023 (February 2, 2023): 1–36. http://dx.doi.org/10.1155/2023/5852315.
Full textNisbet, Lorna A., Fiona M. Wylie, and Karen S. Scott. "Applications of Sample Preparation Techniques in the Analysis of New Psychoactive Substances." Separations 11, no. 9 (2024): 258. http://dx.doi.org/10.3390/separations11090258.
Full textCarfora, Anna, Raffaella Petrella, Giusy Ambrosio, et al. "Toxicological Analysis of Illicit Drugs Seized in Naples (Italy) and First Detection of Synthetic Cannabinoids during COVID-19 Pandemic." Healthcare 10, no. 8 (2022): 1488. http://dx.doi.org/10.3390/healthcare10081488.
Full textTaflaj, Beldisa, Nunzia La Maida, Roberta Tittarelli, Annagiulia Di Trana, and Ilaria D’Acquarica. "New Psychoactive Substances Toxicity: A Systematic Review of Acute and Chronic Psychiatric Effects." International Journal of Molecular Sciences 25, no. 17 (2024): 9484. http://dx.doi.org/10.3390/ijms25179484.
Full textHashim, Ahmed M. M., Ahmed M. Hassan, Ghada Essam El-Din Amin, and Mohamed Farouk Allam. "Prevalence of Strox Smoking Among University Students in Cairo, Egypt." Open Public Health Journal 13, no. 1 (2020): 425–29. http://dx.doi.org/10.2174/1874944502013010425.
Full textdos Santos, Bruno Pereira, Letícia Birk, Patricia de Souza Schwarz, Sarah Eller, Tiago Franco de Oliveira, and Marcelo Dutra Arbo. "A Comprehensive Analysis of Legislative Strategies for New Psychoactive Substances: The Brazilian Panorama." Psychoactives 2, no. 3 (2023): 242–55. http://dx.doi.org/10.3390/psychoactives2030016.
Full textFord, Loretta T., and Jonathan D. Berg. "Analysis of legal high materials by ultra-performance liquid chromatography with time of flight mass spectrometry as part of a toxicology vigilance system: what are the most popular novel psychoactive substances in the UK?" Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 54, no. 2 (2016): 219–29. http://dx.doi.org/10.1177/0004563216651646.
Full textGilani, Farah. "‘Legal highs’: Novel psychoactive substances." InnovAiT: Education and inspiration for general practice 8, no. 12 (2015): 717–24. http://dx.doi.org/10.1177/1755738015612509.
Full textMariotto, Lívia Salviano, Caio Henrique Pinke Rodrigues, and Aline Thais Bruni. "Does Conformation Affect the Analytical Response? A Structural and Infrared Spectral Evaluation of Phenethylamines (2C-H, 25H-NBOH, and 25I-NBOMe) Using In Silico Methodology." Psychoactives 3, no. 1 (2024): 78–92. http://dx.doi.org/10.3390/psychoactives3010006.
Full textSmith, C. D., M. Williams, and M. Shaikh. "Novel psychoactive substances: a novel clinical challenge." Case Reports 2013, aug20 1 (2013): bcr2013200663. http://dx.doi.org/10.1136/bcr-2013-200663.
Full textMazdai, Leila, Matteo Fabbri, Micaela Tirri, et al. "Epigenetic Studies for Evaluation of NPS Toxicity: Focus on Synthetic Cannabinoids and Cathinones." Biomedicines 10, no. 6 (2022): 1398. http://dx.doi.org/10.3390/biomedicines10061398.
Full textAlmeida, Ana Sofia, Rita M. G. Santos, Paula Guedes de Pinho, Fernando Remião, and Carla Fernandes. "Exploring the Impact of Chirality of Synthetic Cannabinoids and Cathinones: A Systematic Review on Enantioresolution Methods and Enantioselectivity Studies." International Journal of Molecular Sciences 26, no. 13 (2025): 6471. https://doi.org/10.3390/ijms26136471.
Full textШУКИМБАЕВА, А. М., М. В. ПРИЛУЦКАЯ, В. Г. СЕНЦОВ, Д. А. МАНСУРОВА, and Б. Е. КЕНЕНБАЕВА. "THE CARDIAC CONSEQUENCES OF NEW PSYCHOACTIVE SUBSTANCES USING (LITERATURE REVIEW)." Farmaciâ Kazahstana, no. 5 (November 28, 2022): 10–22. http://dx.doi.org/10.53511/pharmkaz.2022.96.83.002.
Full textMartinotti, Giovanni, Ornella Corazza, Sophia Achab, and Zsolt Demetrovics. "Novel Psychoactive Substances and Behavioral Addictions." BioMed Research International 2014 (2014): 1–2. http://dx.doi.org/10.1155/2014/534523.
Full textTorrens, M. "Emerging novel psychoactive substances in Europe." European Neuropsychopharmacology 27 (October 2017): S540—S541. http://dx.doi.org/10.1016/s0924-977x(17)31029-5.
Full textOwie, Raven Egheosa, Paul Gosney, Andrew Roney, and Aileen O’Brien. "Psychiatrists’ knowledge of novel psychoactive substances." Drugs and Alcohol Today 17, no. 3 (2017): 178–85. http://dx.doi.org/10.1108/dat-03-2017-0011.
Full text